BCMU
AUXL

BlueCrest Capital Management (UK)’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$243K Buy
+8,125
New +$172K 0.01% 467

Other funds holding AUXL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

BlueCrest Capital Management (UK)'s AUXL Position: Q3 2014 in Review

BlueCrest Capital Management (UK) opened a new position in AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2014: 8,125 shares worth $243K. The stake represents 0.01% of the portfolio and ranks #467 among its holdings.

150 funds tracked by Wall St. Rank hold AUXL as of Q3 2014.

  • BlueCrest Capital Management (UK) held 8,125 shares of AUXILIUM PHARAMCEUTICALS INC worth $243K as of Q3 2014.
  • AUXILIUM PHARAMCEUTICALS INC was a new BlueCrest Capital Management (UK) position in Q3 2014.
  • AUXILIUM PHARAMCEUTICALS INC made up 0.01% of BlueCrest Capital Management (UK)'s portfolio in Q3 2014, its #467 holding.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q3 2014, filed 13 Nov 2014.